TSO3 announces the results of the vote for the election of the members of the Board of Directors

Ticker:  TSX – TOS 
Shares Outstanding: 73,000,906

QUÉBEC CITY, May 8, 2014 /CNW Telbec/ - TSO3 Inc. (TSX: TOS) ("TSO3" or the "Corporation") an innovator in low temperature sterilization technology for medical devices in healthcare settings, announced that the nominees listed in the management proxy circular dated March 18, 2014, were elected as directors of TSO3 Inc.

­Election of Directors

The shareholders were asked to provide their decision via a vote by proxy as part of TSO3 Annual General Meeting of Shareholders, held on May 7, 2014 in Québec.  The detailed results of the vote are set out below.

Name of Nominee

Votes for

% for

Votes

against

%

against

Withheld/

Abstain

% withheld

Germain Carrière

30,431,123

98.83

0

0

361,362

1.17

Pierre Désy

30,429,823

98.82

0

0

362,662

1.18

James R. Husman

26,248,918

85.24

0

0

4,543,567

14.76

Jean Lamarre

26,240,998

85.22

0

0

4,551,487

14.78

W. Barry McDonald

30,421,743

98.80

0

0

370,742

1.20

Claude Michaud

30,438,223

98.85

0

0

354,262

1.15

Richard M. Rumble

30,396,243

98.71

0

0

296,242

1.29

Independent Auditors

24,689,185

77.68

0

0

7,093,803

22.32

 

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2014, will be filed on SEDAR (www.sedar.com) under the name TSO3.

About TSO3

TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals. For more information about TSO3, visit the Company's Web site at www.tso3.com.

The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

SOURCE: TSO3 Inc.

For further information: R.M. (Ric) Rumble, President and CEO, (418) 651-0003, Ext. 254, Email: info@tso3.com

LIENS CONNEXES
http://www.tso3.com

FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.